Asploro Journal of Biomedical and Clinical Case Reports
![Asploro Journal of Biomedical and Clinical Case Reports [ISSN: 2582-0370]](https://i0.wp.com/asploro.com/wp-content/uploads/2022/01/Asploro-Journal-of-Biomedical-and-Clinical-Case-Reports-Volume-5.jpg?resize=853%2C1024&ssl=1)
ISSN: 2582-0370
Article Type: Original Article
DOI: 10.36502/2022/ASJBCCR.6278
Asp Biomed Clin Case Rep. 2022 Oct 22;5(3):146-51
Hiroshi BANDO1,2,3iD*, Hisako YAMASHITA3, Yoshinobu KATO3, Takafumi KAWATA3, Yoshikane KATO3, Hiroe KANAGAWA3
1Tokushima University / Medical Research, Tokushima, Japan
2Japan Low Carbohydrate Diet Promotion Association, Kyoto, Japan
3Kanaiso Hospital, Tokushima, Japan
Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ORCID iD
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 24 September 2022; Accepted date: 15 October 2022; Published date: 22 October 2022
Citation: Bando H, Yamashita H, Kato Y, Kawata T, Kato Y, Kanagawa H. Seasonal Variation of Glucose Variability in Rather Elderly Patients with Type 2 Diabetes (T2D) Treated by Vildagliptin and Metformin (EquMet). Asp Biomed Clin Case Rep. 2022 Oct 22;5(3):146-51.
Copyright © 2022 Bando H, Yamashita H, Kato Y, Kawata T, Kato Y, Kanagawa H. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
Keywords: Seasonal variation of HbA1c, Type 2 Diabetes, Cardiovascular Disease, EquMet, Ramadan
Abbreviations: T2D: Type 2 Diabetes; CVD: Cardiovascular Disease
Abstract
Background: Seasonal variation of HbA1c has been in focus.
Patients and Methods: The protocol included type 2 diabetes (T2D) patients (n=26, 71.4±10.2 years) on vildagliptin and metformin (EquMet) and HbA1c changes in 4 seasons for 6 years.
Results: HbA1c values ranged 6.9-7.5%, and tend to show highest in winter, and rather lower in autumn.
Discussion & Conclusion: Rather elderly T2D cases can tolerate EquMet with fair control. Previous reports showed a similar tendency. Some factors may be involved in the variation, such as temperature, climate, carbohydrate intake, Ramadan, and others. Furthermore, blood pressure and cardiovascular disease (CVD) can also influence them.
